Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1974 Apr;50(4):481–487. doi: 10.1111/j.1476-5381.1974.tb08581.x

A central vasodepressor effect of dyflos

H Edery, PG Guertzenstein
PMCID: PMC1776720  PMID: 4614881

Abstract

1 Cats were anaesthetized with pentobarbitone sodium and atropinized peripherally by intravenous injection of atropine methyl nitrate; the effect was examined of topical bilateral application of dyflos to the ventral surface of the medulla oblongata at a region lateral to the pyramids and caudal to the trapezoid bodies. Dyflos was applied by means of perspex rings; the volume of fluid placed in each ring was 10 μl.

2 The topical application of dyflos (1-20 mg/ml) produced a fall in arterial blood pressure without changes in heart rate and, in experiments without artificial ventilation, tachypnoea with dissociation of thoracic and abdominal respiration.

3 Atropine methyl nitrate (50 mg/ml) applied topically in the same way as dyflos, prevented or abolished its vasodepressor effect.

4 The two reactivators of acetylcholinesterase, obidoxime (100-200 mg/ml) and pralidoxime mesylate (100-200 mg/ml), applied topically in the same way as dyflos, abolished its vasodepressor effect. The reactivator compound 30 (100 mg/ml), also a pyridinium aldoxime, did not have this effect.

5 Obidoxime and pralidoxime mesylate also reversed the vasodepression produced by carbachol applied to the ventral surface of the brain stem but not the vasodepression produced by glycine similarly applied.

6 The problem is discussed as to whether the reversal of the dyflos and carbachol-induced vasodepression by obidoxime and pralidoxime is due to acetylcholinesterase reactivation by dephosphorylation and decarbamylation respectively, to a central atropine-like action of these compounds or to a combination of both.

Full text

PDF
481

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BETHE K., ERDMANN W. D., LENDLE L., SCHMIDT G. Spezifische Antidot-Behandlung bei protrahierter Vergiftung mit Alkylphosphaten (Paraoxon, Parathion, DFP) und Eserin an Meerschweinchen. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1957;231(1):3–22. [PubMed] [Google Scholar]
  2. Borison H. L., Haranath P. S., McCarthy L. E. Respiratory responses to chemical pulses in the cerebrospinal fluid of cats. Br J Pharmacol. 1972 Apr;44(4):605–616. doi: 10.1111/j.1476-5381.1972.tb07300.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bousquet P., Guertzenstein P. G. Localization of the central cardiovascular action of clonidine. Br J Pharmacol. 1973 Dec;49(4):573–579. doi: 10.1111/j.1476-5381.1973.tb08532.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. ERDMANN W. D., ENGELHARD H. PHARMAKOLOGISCH-TOXIKOLOGISCHE UNTERSUCHUNGEN MIT DEM DICHLORID DES BIS- Arzneimittelforschung. 1964 Jan;14:5–11. [PubMed] [Google Scholar]
  5. Edery H., Soroker D., Kuhnberg W. Antidotal action of new oximes in experimental organophosphate intoxication. Isr J Med Sci. 1970 Mar-Apr;6(2):209–218. [PubMed] [Google Scholar]
  6. Feldberg W., Guertzenstein P. G. A vasodepressor effect of pentobarbitone sodium. J Physiol. 1972 Jul;224(1):83–103. doi: 10.1113/jphysiol.1972.sp009882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Guertzenstein P. G. Blood pressure effects obtained by drugs applied to the ventral surface of the brain stem. J Physiol. 1973 Mar;229(2):395–408. doi: 10.1113/jphysiol.1973.sp010145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HOBBIGER F., SADLER P. W. Protection against lethal organophosphate poisoning by quaternary pyridine aldoximes. Br J Pharmacol Chemother. 1959 Jun;14(2):192–201. doi: 10.1111/j.1476-5381.1959.tb01383.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kuhnen-Clausen D. Investigations on the parasympatholytic effect of toxogonin on the guinea-pig isolated ileum. Eur J Pharmacol. 1970 Jan;9(1):85–92. doi: 10.1016/0014-2999(70)90324-9. [DOI] [PubMed] [Google Scholar]
  10. LEHMAN R. A. Mechanism of the antagonism by pralidoxime and 1,1-trimethylenebis(4-hydroxyiminomethylpyridinium) of the action of echothiphate on the intestine. Br J Pharmacol Chemother. 1962 Apr;18:287–298. doi: 10.1111/j.1476-5381.1962.tb01408.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Preston E., Heath C. Atropine-insensitive vasodilatation and hypotension in the organophosphate-poisoned rabbit. Arch Int Pharmacodyn Ther. 1972 Dec;200(2):231–244. [PubMed] [Google Scholar]
  12. Reiner E., Aldridge W. N. Effect of pH on inhibition and spontaneous reactivation of acetylcholinesterase treated with esters of phosphorus acids and of carbamic acids. Biochem J. 1967 Oct;105(1):171–179. doi: 10.1042/bj1050171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Trouth C. O., Loeschcke H. H., Berndt J. Topography of the respiratory responses to electrical stimulation in the medulla oblongata. Pflugers Arch. 1973 Mar 21;339(2):153–170. doi: 10.1007/BF00587181. [DOI] [PubMed] [Google Scholar]
  14. WILSON I. B., HARRISON M. A., GINSBURG S. Carbamyl derivatives of acetylcholinesterase. J Biol Chem. 1961 May;236:1498–1500. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES